Advertisement

Neuere Aspekte der psychopharmakologischen Rehabilitation mit Antikonvulsiva

  • D. Bremer
  • M. Dose
  • H. M. Emrich
Conference paper

Zusammenfassung

Sinn und Zweck einer psychopharmakologischen Rehabilitation ist eine über die bloße Akuttherapie hinausgehende medikamentöse Behandlung der psychiatrischen Patienten, die an längerfristigen psychotischen Störungen leiden und ohne eingreifendere somatische Therapien nicht zur Remission gebracht werden können bzw. wieder rezidivieren.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Ballenger JC, Post RM (1980) Carbamazepine in manic-depressive illness: a new treatment. Am J Psychiatry 137:782–790PubMedGoogle Scholar
  2. Dose M, Apelt S, Emrich HM (1987) Carbamazepine as an adjunct of antipsychotic therapy. Psychiatry Res 22:303–310PubMedCrossRefGoogle Scholar
  3. Emrich HM (1986) Alternativen zur Lithiumprophylaxe. In: Müller-Oerlinghausen B, Greil W (Hrsg) Die Lithiumtherapie. Nutzen, Risiken, Alternativen. Springer, Berlin Heidelberg New York, S 356–368Google Scholar
  4. Emrich HM (1982) Prophylactic therapies in affective disorders: mode of action from a clinical point of view. In: Emrich HM, Aldenhoff JB, Lux HD (eds) Basic mechanisms in the action of lithium. Excerpta Medica, Amsterdam, pp 202–214Google Scholar
  5. Emrich HM, Dose M, Zerssen D von (1984a) Action of sodium valproate and of oxcarbazepine in patients with affective disorders. In: Emrich HM, Okuma T, Müller AA (eds) Anticonvulsants in affective disorders. Excerpta Medica, Amsterdam, pp 45–55Google Scholar
  6. Emrich HM, Okuma T, Müller AA (eds) (1984b) Anticonvulsants in affective disorders. Excerpta Medica, AmsterdamGoogle Scholar
  7. Haag H, Greil W, Bender W, Rüther E (1985) Tardive dyskinesia and medication history. Pharmacopsychiatry 18:35–36CrossRefGoogle Scholar
  8. Lambert PA, Carraz G, Borselli S, Carrel S (1966) Action neuropsychotrope d’un nouvel anti-èpileptique: Le Dèpamide. Ann Med Psychol (Paris) 1:707–710Google Scholar
  9. Müller-Oerlinghausen B, Greil W (Hrsg) (1986) Die Lithiumtherapie. Nutzen, Risiken, Alternativen. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  10. Okuma T, Kishimoto A, Inoue K, et al (1973) Antimanic and prophylactic effects of carbamazepine (Tegretal) on manic depressive psychoses. A preliminary report. Folia Psychiat Neurol Jpn 27:283–297PubMedGoogle Scholar
  11. Okuma T, Kishimoto A, Inoue K, Ogura C, Motoike M (1975) Carbamazepine (Tegretal) in mania. Seishin Igaku 17:617–630Google Scholar
  12. Post RM, Uhde TW (1983) Treatment of mood disorders with antiepileptic medications: Clinical and theoretical implications. Epilepsia [Suppl 2] 24:97–108CrossRefGoogle Scholar
  13. Post RM, Uhde TW, Ballenger JC, Squillace KM (1983) Prophylactic efficacy in manic-depressive illness. Am J Psychiatry 140:1602–1604PubMedGoogle Scholar
  14. Schou M (1974) Heutiger Stand der Lithium-Rezidivprophylaxe bei endogenen affektiven Erkrankungen. Nervenarzt 45:397–418PubMedGoogle Scholar
  15. Takezaki H, Hanaoka M (1971) The use of carbamazepine (Tegretal) in the control of manic-depressive psychosis and other manic-depressive states. Clin Psychiatry 13:173–183Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1989

Authors and Affiliations

  • D. Bremer
  • M. Dose
  • H. M. Emrich

There are no affiliations available

Personalised recommendations